MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Restoration of Ambulation in an Adolescent with Tardive Dystonia after Pallidal DBS

    HB. Burks, T. Larsh, J. Skoch, DL. Gilbert, SW. Wu (Cincinnati, USA)

  • Results From a Dose-Blinded, Phase II Extension Study Evaluating Long-Term Efficacy, Safety and Tolerability of Minzasolmin in Participants With Parkinson’s Disease

    C. Beuter, S. Carson, M. Key Prato, N. Massat, R. Maguire, A. Dhar Koul, E. Lucassen, J-M. Riethusien, I. Giunzioni, A. Pethe, G. Goethals, A. Khanna, Z. Ali (Monheim am Rhein, Germany)

  • Results from the PRIME-UK Randomised Controlled Trial

    K. Lloyd, E. Tenison, C. Mcdonald, S. Haworth, C. Glover, R. Harrison, D. Pendry-Brazier, M. Smith, F. Lithander, A. Cullen, K. Naylor, N. Giles, T. Gabriel, P. Kamnerdsupaphon, A. Nodehi, Y. Ben-Shlomo, EJ. Henderson (Bristol, United Kingdom)

  • Retention & Safety in a Home-Based Fracture Prevention Trial of Zoledronate vs Placebo (TOPAZ) in Persons with Neurodegenerative Parkinsonism (NDP)

    C. Tanner, N. Luthra, S. Goldman, R. Zuzuarregui, E. Brown, C. Meng, J. Perkins, L. Racelo, T. Hue, C. Schambach, D. Kriesel, H. Barnes, T. Stiep, I. Bledsoe, P. Ranola, M. Schwarzschild, R. Dorsey, A. Espay, S. Krischer, C. Comella, M. Siddiqui, F. Gao, M. Ledoux, E. Byrd, I. Litvan, N. Mcfarland, K. Mitchell, D. Standaert, J. Beck, K. Williams, M. Drake, D. Bauer, K. Lyles, S. Cummings, THE. Topaz Study-Team (San Francisco, USA)

  • Rethinking Parkinsonism: Limitations in Clinical Diagnosis

    S. Lallani, K. Poston (Stanford, USA)

  • Retinal Structural Changes in Parkinson’s Disease: insight into GBA1-Related PD and non-mutated PD

    G. Di Rauso, M. Giacomelli, G. Portaro, S. Grisanti, V. Fioravanti, L. Caprari, G. Toschi, G. Argenziano, R. Sabadini, L. Taruffi, A. Scaglioni, E. Monfrini, A. Di Fonzo, M. Vecchi, F. Cavallieri, F. Valzania (Reggio Emilia, Italy)

  • Retro walking: A Potential Indicator of Physical Frailty in Parkinson’s Disease.

    M. van Emde-Boas, C. Stonsaovapak, N. Bohnen, C. Pongmala (Ann Arbor, USA)

  • Retrospective analysis of MSA diagnosis in a neuroscience hospital

    M. Wazil, M. Farhan Abdulla, J. Mitchell, D. Damodaran (Liverpool, United Kingdom)

  • Retrospective Analysis of our Supportive Care Clinic and Lifestyle Improvement Fitness Program

    N. Hellmers, A. Weiss, B. Katz, S. Fine, A. Aminpour, A. Yoo, H. Ooi, H. Sarva (New York, USA)

  • Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

    E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)

  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley